Business Trip Greg Kubin & Matias Serebrinsky

Today’s episode features Dylan Beynon from Mindbloom, a mental and wellbeing startup that is currently offering ketamine-assisted therapy to treat anxiety and depression. Mindbloom is opening clinics across the country and is using technology to lower the cost of treatment. Host Greg Kubin participates in a ketamine-assisted therapy session in the episode.

And that ethereal track you hear during the ketamine session is called Happiness Frequency by Conscious Sounds 432hz.

Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin
Produced by Jonathan A. Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh
Read the transcript here.

Watch episode 1 on YouTube.

Music: Sal by Xylo-Ziko, Ocean Waves by Siddhartha Corsus, Sun Heights by Muted Circus, Sita’s Song by Siddhartha Corsus, and Fair Detective by Muted Circus.

Find us at businesstrip.fm
Follow us on Instagram and Twitter!

Find us at businesstrip.fm

Today’s episode features Shelby Hartman and Madison Margolin from DoubleBlind, a psychedelic magazine and media company founded in 2019 covering timely, untold stories about the expansion of psychedelics around the globe. Focused on how the industry can engage in sacred reciprocity and ethical psychedelic therapies, DoubleBlind is a for-profit company working on becoming a fully licensed certified B corporation.


Links to topics discussed in this episode:
What It’s Like to Have Sex on Different Kinds of Psychedelics
How Oregon is Leading the Country in Drug Policy Reform
Entheogen: Definition and History
How Psychedelics are Reigniting Judaism
Michael Pollan's book How to Change Your Mind
Ayelet Waldman's book: A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life
MDMA Testing Kits from DanceSafe

Read the transcript here.

Watch episode 2 on YouTube.

Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin
Produced by Jonathan A. Davis

Find us at businesstrip.fm
Follow us on Instagram and Twitter!

Theme music by Dorian Love
Additional music: Plasticity by Blue Dot Sessions


IsEbOcbXwtgQS6Jzz1Eb

Today's episode features Ryan Zurrer, founder of Vine Ventures, one of the first venture capital funds investing in psychedelic medicine. Ryan has deep roots in psychedelics culture and understands the many cultures within the psychedelic space. His fund is aligned with those values.
If you’re a founder, investor, or early hire at a psychedelic company, this episode is a must-listen!
In this episode, we discuss:
Which psychedelic business models are a good fit for venture capital?Why did Ryan start Vine Ventures?What traits of entrepreneurs does Ryan invest in?Which form of psychedelic medicine is better: natural or synthetic compounds? 
Links to topics discussed in this episode:
Pharmauasca
Oregon Initiative Measure 109
ENTHEON
PsyGen
California Sober
Atai
Compass
Get in touch with Ryan Zurrer - TW: @rzurrer LI: Ryan Zurrer

Read the transcript here.
Watch episode 3 on YouTube.
Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin
Produced by Jonathan A. Davis


Find us at businesstrip.fm
Follow us on Instagram and Twitter!


Theme music by Dorian Love
Additional music by Blue Dot Sessions and Chad Crouch

Today's episode features David Champion, CEO and co-founder of Maya, a software platform that helps practitioners and clinics manage psychedelic-assisted therapy practices. The data collected from treatments will help psychedelic stakeholders, from researchers to pharmaceutical companies, discover insights for safer and more effective treatments.
In this episode, we discuss:
Removing the guesswork from developing psychedelic therapy protocolsFundraising tips for psychedelic company foundersThe role of data in surfacing safer and more effective treatmentsA big announcement from Matias and Greg!Links to topics discussed in this episode:
Zendo Project - Subsidiary of MAPS
Johns Hopkins - Center for Psychedelic and Consciousness Research
MAPS
CIIS
EMR & EHR - What's the difference?


Read the transcript here.
Watch episode 4 on YouTube.
Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin
Produced by Jonathan A. Davis
Marketing by DaisyMae VanValkenburgh


Find us at businesstrip.fm
Follow us on Instagram and Twitter!


Theme music by Dorian Love
Additional music by Blue Dot Sessions.

Today's episode features Flor Bollini, founder of NANA, an online platform that guides patients on using psychedelic medicine for holistic healing.
NANA provides personalized protocols based on an assessment of your mental, emotional and physical health. From there you are partnered with a Nana or guide who leads telemedicine therapy that incorporates ketamine, cannabis and CBD.
Flor hopes these protocols will become best practices for patients, clinics, and the psychedelic medicine ecosystem.
In this episode, we discuss:
Why Flor transitioned from serving medicine to company founderDeveloping protocols where the FDA doesn’t regulateThe benefits of progressive dosingHer experiences with 5-MeO-DMT and Iboga. “The Everest of psychedelics” as she calls them.

Links to topics discussed in this episode:
UNESCO - United Nations Educational, Scientific and Cultural Organization
Ifa - Ancient Divination System
Ayurveda
Jungian
5-MeO-DMT
LMS - Learning Management System
REM Sleep - Rapid Eye Movement Sleep
SSRIs - Selective Serotonin Reuptake Inhibitors
Ayahuasca
Ibogaine
Bwiti religion
Serotonin Syndrome

Read the transcript here.
Watch episode 5 on YouTube.
Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin
Produced by Jonathan A. Davis
Marketing by DaisyMae VanValkenburgh


Find us at businesstrip.fm
Follow us on Instagram and Twitter!


Theme music by Dorian Love
Additional music by Blue Dot Sessions.

Today's episode features Danny Motyka, founder of Psygen, a Canadian manufacturer of psychedelics, like MDMA, LSD, DMT, and synthetic psilocybin.
Psygen makes pharmaceutical grade psychedelic medicines for clinical research and therapeutic applications. They have a license to be one of the first manufacturing facilities dedicated to the synthesis of psychedelic medicine. 
In this episode, we discuss:
Behind the scenes of Psygen’s manufacturing processNatural vs Synthetic psychedelicsNavigating regulations for manufacturing Schedule 1 substancesLinks to topics discussed in this episode:
GMP
Dr. Peter van der Heyden
COMP360
Entourage Effect
Health Canada
Nick Sand - Orange Sunshine
MDMA, LSD, 5-MeO-DMT, Ibogaine, Psilocybin
Entheon Biomedical
MAPS
2C-B


Read the transcript here.
Watch episode 6 on YouTube.
Created by Greg Kubin and Matias Serebrinsky
Host: Greg Kubin
Produced by Jonathan A. Davis & Zack Frank
Marketing by DaisyMae VanValkenburgh


Find us at businesstrip.fm
Follow us on Instagram and Twitter!


Theme music by Dorian Love
Additional music by Crystals by Xylo-Ziko, Obscure Train by Revolution Void, Love Chances by Makaih Beats, and Kleptotonic Swing by Tri-Tachyon